BioVie(BIVI)

1.48 -0.02 -1.3333%

今开:1.49昨收:1.5
最高:1.515 最低:1.415
涨停价:0.0跌停价:0.0
总市值:1.1151918E7

BioVie的热门讨论

年度财报

BioVie(BIVI)08-16 05:15

$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-25-000268  Act: 34  Size: 5 MB 网页链接查看全文

招股信息更正说明

BioVie(BIVI)10-06 18:05

$BioVie(BIVI)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001520138-25-000294  Act: 33  Size: 595 KB 网页链接查看全文

股东委托书协议

BioVie(BIVI)09-26 05:35

$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-25-000287  Act: 34  Size: 728 KB 网页链接查看全文

其他

BioVie(BIVI)10-06 18:05

$BioVie(BIVI)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001520138-25-000293  Act: 33  Size: 246 KB 网页链接查看全文

首次持股声明

BioVie(BIVI)10-28 06:45

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000326  Size: 8 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)08-14 04:15

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-25-000251  Size: 7 KB 网页链接查看全文

招股说明书

BioVie(BIVI)10-06 18:05

$BioVie(BIVI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001520138-25-000292  Act: 33  Size: 791 KB 网页链接查看全文

首次持股声明

BioVie(BIVI)10-28 23:25

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000327  Size: 8 KB 网页链接查看全文

当期报告

BioVie(BIVI)08-12 04:35

$BioVie(BIVI)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001520138-25-000249  Act: 34  Size: 1 MB 网页链接查看全文

BioVie的最新讨论

首次持股声明

BioVie(BIVI)2021-09-29 01:27

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-21-000576  Size: 9 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)2021-09-17 02:42

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-21-000556  Size: 12 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)2021-09-17 00:57

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-21-000550  Size: 11 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)2021-09-17 00:57

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-21-000552  Size: 11 KB 网页链接查看全文

持股变动声明

BioVie(BIVI)2021-09-17 00:51

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-21-000548  Size: 11 KB 网页链接查看全文

股东委托书协议

BioVie(BIVI)2021-09-14 18:06

$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-21-000537  Act: 34  Size: 523 KB 网页链接查看全文

年度财报

BioVie(BIVI)2021-08-31 05:21

$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-21-000509  Act: 34  Size: 4 MB 网页链接查看全文

当期报告

BioVie(BIVI)2021-08-12 01:27

$BioVie(BIVI)$ 8-K Current report, items 1.01, 7.01, 8.01, and 9.01 Accession Number: 0001520138-21-000423  Act: 34  Size: 592 KB 网页链接查看全文

TOPVIEW | 2021.8.9 Bio-market主要涨跌一览

蹊之美股生物医药2021-08-10 20:25

作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers: 
Liminal BioSciences (NASDAQ:LMNL) +27%
Allied Healthcare Products (NASDAQ:AHPI) +22%
SCWorx (NASDAQ:WORX) +18%
\NRx Pharmaceuticals (NASDAQ:NRXP) +14%
Windtree Therap...查看全文

招股说明书

BioVie(BIVI)2021-08-10 18:12

$BioVie(BIVI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001520138-21-000407  Act: 33  Size: 452 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

BioVie的公告

首次持股声明

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000327  Size: 8 KB 网页链接

首次持股声明

$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000326  Size: 8 KB 网页链接

招股说明书

$BioVie(BIVI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001520138-25-000292  Act: 33  Size: 791 KB 网页链接

其他

$BioVie(BIVI)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001520138-25-000293  Act: 33  Size: 246 KB 网页链接

招股信息更正说明

$BioVie(BIVI)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001520138-25-000294  Act: 33  Size: 595 KB 网页链接

股东委托书协议

$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-25-000287  Act: 34  Size: 728 KB 网页链接

年度财报

$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-25-000268  Act: 34  Size: 5 MB 网页链接

持股变动声明

$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-25-000251  Size: 7 KB 网页链接

当期报告

$BioVie(BIVI)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001520138-25-000249  Act: 34  Size: 1 MB 网页链接

招股说明书

$BioVie(BIVI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001520138-25-000247  Act: 33  Size: 8 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31